Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
anti-anb3 integrin (1 trial)
octreotide (sandostatin) (1 trial)
vatalanib (1 trial)
Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)